search
biosimilars
Trends
- 1Biosimilars Touted as a Path to Lower Drug Costs●Biosimilars: The Prescription for Lower Costs & Improved Access
Physicians Weekly reports on biosimilars, lower-cost copies of biologic medicines, arguing they can reduce prescription drug prices and improve patient access to expensive treatments. The piece frames wider biosimilar adoption as a way to ease healthcare cost pressures while maintaining treatment quality.
- 2Biosimilars Sector Poised for M&A Shake-Up as Patent Cliff Looms●Biosimilars at an Inflection Point: How Regulatory Reform, a Maturing Patent Framework and a Looming Patent Cliff Are Reshaping M&A
Legal and industry analysts say the biosimilars market has reached an inflection point, with regulatory reform, a maturing patent litigation framework and an approaching wave of major biologic patent expirations reshaping merger and acquisition strategy. Commentators expect pharmaceutical companies to pursue deals to capture market share as blockbuster biologics lose exclusivity and cheaper biosimilar competition intensifies.